What is NDC 0006-3516?

0006-3516 is the product NDC for Primaxin IV, Imipenem 500 mg/100mL; Cilastatin sodium 500 mg/100mL injection, powder, for solution, listed with the FDA by Merck Sharp & Dohme LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Primaxin IV (Imipenem and cilastatin sodium).

Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Primaxin IV?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Primaxin IV NDC 0006-3516 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0006-3516Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00006-3516Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0006-3516-59	00006351659	25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3516-59) / 100 mL in 1 VIAL, SINGLE-DOSEMarketed from Nov 26, 1985

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Primaxin IVSuffix: IV
Generic name (nonproprietary): imipenem and cilastatin sodium
Active ingredients: Imipenem — 500 mg/100mLCilastatin sodium — 500 mg/100mL
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Merck Sharp & Dohme LLCNDC labeler code 0006
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 050587
Marketing start: Nov 26, 1985
Listing expires: Dec 31, 2026
Other FDA classes: Carbapenems (Chemical structure)Dipeptidase Inhibitors (Mechanism)
Identifiers: Product ID 0006-3516_34854f9b-7be0-4bfb-8cd2-40baf206fb80SPL ID 34854f9b-7be0-4bfb-8cd2-40baf206fb80SPL set ID f41d8abd-7792-4918-1b93-bd83ea01955eRxCUI 1726204, 1726207, 1726214, 1726216UNII 71OTZ9ZE0A, 5428WXZ74MUPC 0300063516594
Pharmacologic class: Penem Antibacterial; Renal Dehydropeptidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400006351659 followed by a unit qualifier and the quantity

Package 00006-3516-59. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 5, 2024.

Indications (excerpt from the label)

PRIMAXIN for intravenous use is a combination of imipenem, a penem antibacterial, and cilastatin, a renal dehydropeptidase inhibitor, indicated for the treatment of the following serious infections caused by designated susceptible bacteria: Lower respiratory tract infections. ( 1.1 ) Urinary tract infections. ( 1.2 ) Intra-abdominal infections. ( 1.3 ) Gynecologic infections. ( 1.4 ) Bacterial septicemia. ( 1.5 ) Bone and joint infections. ( 1.6 ) Skin and skin structure infections. ( 1.7 ) Endocarditis. ( 1.8 ) Limitations of Use: PRIMAXIN is not indicated in patients with meningitis because safety and efficacy have not been established ( 1.9 ). PRIMAXIN is not recommended in pediatric pati…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0006-3516

What is NDC 0006-3516?: 0006-3516 is the product NDC for Primaxin IV, Imipenem 500 mg/100mL; Cilastatin sodium 500 mg/100mL injection, powder, for solution, listed with the FDA by Merck Sharp & Dohme LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Primaxin IV (Imipenem and cilastatin sodium).
What is the active ingredient?: Imipenem, Cilastatin sodium.
Who is the labeler?: Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Primaxin IV?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Primaxin IV (Imipenem and cilastatin sodium) NDC 0006-3516